Has Bethany Austin, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,109 in general payments to Bethany Austin, MD across 3 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bethany Austin, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bethany Austin, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bethany Austin, MD

Advanced Heart Failure and Transplant Cardiology · Kansas City, MONPI 1720258122

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $831 of the $1,109 with a category attached, or 75.0%. Abiomed accounts for 75.0% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in MO, where the typical reported total is $7,967.

$1,109in general payments, 2019–2025

Across 3 payments — averaging $369.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abiomed$831
Amgen$278

$132,307in research payments, 2019–2025

Across 46 payments — averaging $2876.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bayer$69K
Abbott$64K

What the payments were for

Travel & lodging$83175%
Food & beverage$27825%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abiomed	1	$831
Amgen	2	$278

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Impella$831
Repatha$137

How this compares

$1,109 in reported general payments places this provider in the 15th percentile of 26 advanced heart failure and transplant cardiology providers in Missouri.

See all advanced heart failure and transplant cardiology providers in Missouri →

Medicare billing

Part B allowed, 2024

$90,590

Medicare patients

978

Services billed

1,617

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EntrestoSacubitril/Valsartan	206	$257,040
JardianceEmpagliflozin	133	$158,865
EliquisApixaban	117	$133,373
Repatha SureclickEvolocumab	52	$31,734
XareltoRivaroxaban	32	$28,019
FarxigaDapagliflozin Propanediol	22	$26,132
VascepaIcosapent Ethyl	16	$7,072
Tacrolimus	48	$6,289
Potassium Chloride	168	$5,583
Torsemide	168	$4,736
Isosorbide Dinit-HydralazineIsosorbide Dinit/Hydralazine	12	$4,262
Sirolimus	15	$2,961
Metoprolol Succinate	181	$2,764
Mycophenolate Mofetil	29	$2,328
Valsartan	81	$2,156

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Kansas City

Brett SperryKansas City$314K
Michael NassifKansas City$32K
Andrew KaoKansas City$9K
Taiyeb KhumriKansas City$2K
Stephanie LawhornKansas City$238
Mark EverleyKansas City$119
Andrew SauerLees Summit$411K
Gerard OghlakianSpringfield$365K
Shane LarueHannibal$41K
Gregory EwaldSaint Louis$35K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →